ZBTB16 and non-small cell lung carcinoma: The tumour suppressor ZBTB16 was found to be downregulated in non-small-cell lung cancer, decreased expression levels may contribute to cell survival, and overexpression was found to increase apoptosis and inhibit proliferation [51].